If your insurance denies coverage for weight loss, we will offer you self-pay options
The sustained nature of the weight loss observed in this study would be in line with clinical findings that show greater weight loss with tirzepatide compared to semaglutide [47]
5,6,7 The FDA recommends semaglutide for weight loss if patients meet one of the following criteria: Body Mass Index (BMI) 27 kg/m2 (overweight) and have a weight-related comorbidity (e.g., high blood pressure, type 2 diabetes, hypercholesterolemia)
Therapy is available only after medical evaluation and prescribed by a licensed provider
Small studies have shown inconsistent results, and theres no strong evidence that it meaningfully improves menopause or PMS symptoms.38 Taken together, these ingredients provide overlapping support for both menopause-related symptoms and PMS, which helps explain why this formula performs well across both categories even if not every component is equally well supported by research